An in vivo platform to select and evolve aggregation-resistant proteins. (2020)
Attributed to:
In vivo selection of bioprocessable biopharmaceuticals
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-020-15667-1
PubMed Identifier: 32286330
Publication URI: http://europepmc.org/abstract/MED/32286330
Type: Journal Article/Review
Volume: 11
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723